WAM
BSX icon

Wolverine Asset Management’s Boston Scientific BSX Stock Holding History

Wolverine Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-40
Closed -$1K – 2459
2013
Q4 		$1K Hold
40
– – ﹤0.01% 2558
2013
Q3 		$2K Buy
+40
New +$433 ﹤0.01% 2509

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Wolverine Asset Management's BSX Position: Q3 2022 in Review

Wolverine Asset Management sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 57,333 shares — an estimated $2.14M sold.

Wolverine Asset Management first reported a position in BSX in Q2 2013 and held it in 13 quarters. The position peaked at $13.2M in Q4 2020. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Wolverine Asset Management reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 57,333 Boston Scientific shares in Q3 2022, an estimated $2.14M.
  • Wolverine Asset Management first reported a position in Boston Scientific in Q2 2013 and held it in 13 quarters.
  • Wolverine Asset Management's Boston Scientific position peaked at $13.2M in Q4 2020.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.